Korean Drug Co., Ltd. (KOSDAQ:014570)
South Korea · Delayed Price · Currency is KRW 3,395.00
-55.00 (-1.59%)
At close: May 29, 2026
Korean Drug Market Cap
Korean Drug has a market cap or net worth of 38.08 billion as of May 29, 2026. Its market cap has decreased by -27.67% in one year.
Market Cap
38.08B
Enterprise Value
3.63B
Revenue
62.76B
Ranking
n/a
PE Ratio
5.51
Stock Price
3,395.00
Market Cap Chart
Since March 31, 2005, Korean Drug's market cap has increased from 12.54B to 38.08B, an increase of 203.69%. That is a compound annual growth rate of 5.38%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 1, 2026 | 38.08B | -18.84% |
| Dec 30, 2025 | 46.92B | -6.42% |
| Dec 30, 2024 | 50.14B | -36.00% |
| Dec 28, 2023 | 78.35B | -8.30% |
| Dec 29, 2022 | 85.44B | -12.32% |
| Dec 30, 2021 | 97.44B | -13.30% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BL Pharmtech | 50.88B |
| RP Bio | 49.92B |
| Korea Arlico Pharm | 43.84B |
| Eagle Veterinary Technology Co.,Ltd | 42.92B |
| HLscience | 34.84B |
| Kyung Nam Pharm | 34.23B |
| GeneBioTech Co. ,Ltd | 33.80B |
| Baskhanbio Pharma | 30.18B |